Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.

0 Mins
Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients abroad remains unclear.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago